Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693620017 | Product containing precisely methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3693621018 | Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Is a | 5-aminolevulinic acid only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Is a | Methyl aminolevulinate product | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Is a | Methyl aminolevulinate product | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has active ingredient | Methyl aminolevulinate | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Is a | Product manufactured as cutaneous dose form | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has concentration strength numerator value | 160 | false | Inferred relationship | Some | 1 | |
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has BoSS | Methyl aminolevulinate | true | Inferred relationship | Some | 1 | |
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 mg/g cutaneous cream | Has precise active ingredient | Methyl aminolevulinate hydrochloride | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR